Happiness Biotech Group (NASDAQ:HAPP) Earns Buy Rating from Analysts at Aegis

Aegis began coverage on shares of Happiness Biotech Group (NASDAQ:HAPP) in a research report report published on Friday, The Fly reports. The brokerage issued a buy rating on the stock.

Shares of HAPP stock opened at $4.80 on Friday. Happiness Biotech Group has a fifty-two week low of $3.91 and a fifty-two week high of $5.24.

Happiness Biotech Group Company Profile

Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplements products made of Lucidum spore powder and others in the People's Republic of China. It also offers edible fungi. The company was founded in 2004 and is based in Nanping, the People's Republic of China.

Featured Article: What are Closed-End Mutual Funds?

The Fly

Receive News & Ratings for Happiness Biotech Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Happiness Biotech Group and related companies with MarketBeat.com's FREE daily email newsletter.